Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00599820
NCT00599820
Terminated
Phase 3

OCT, Visual Outcome and Angiographic Analysis of Choroidal Neovascularization in Six Eyes With Angioid Streaks Treated With a Single Intravitreal Injection of Bevacizumab

Asociación para Evitar la Ceguera en México1 site in 1 countryNovember 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAngioid StreaksChoroidal Neovascularization
DrugsIntravitreal Bevacizumab

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Angioid Streaks
Sponsor
Asociación para Evitar la Ceguera en México
Locations
1
Primary Endpoint
Optical Coherence Tomography
Status
Terminated
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

Intravitreal Bevacizumab is an effective treatment for choroidal neovascularization secondary to Angioid Streaks

Detailed Description

A consecutive case series of patients with angioid streaks that developed subfoveal choroidal neovascularization were treated with a primary 2.5 mg injection of Bevacizumab (Avastin) intravitreally. All patients were evaluated with BCVA at 1, 2 , 4 and 12 weeks and OCT and fluoresceine angiography at month 1 and 3. (Patients will be follow 6 months)

Registry
clinicaltrials.gov
Start Date
November 2005
End Date
May 2006
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Asociación para Evitar la Ceguera en México

Eligibility Criteria

Inclusion Criteria

  • •Clinical diagnosis of Angioid Streaks
  • •Choroidal neovascularization associated
  • •Untreated patients or patients treated once with PDT

Exclusion Criteria

  • •Ocular surgery excepting uncomplicated phacoemulsification
  • •Glaucoma or any other ocular pathology

Outcomes

Primary Outcomes

Optical Coherence Tomography

BCVA

Fluoresceine Angiography

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 1
Intravitreal Bevacizumab in Agioid StreaksAngioid StreaksChoroidal Neovascularization
NCT00406250University of Campania "Luigi Vanvitelli"5
Completed
Phase 4
Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular DegenerationAge Related Macular Degeneration
NCT00556348Instituto de Olhos de Goiania500
Completed
Phase 4
Bevacizumab Intravitreal for Myopic Choroidal NeovascularizationMyopic Choroidal Neovascularization
NCT00797992Instituto de Olhos de Goiania5
Recruiting
Not Applicable
Treatment with bevacizumab for ocular vascular lesionsOcular vascular lesions
JPRN-UMIN000020916Keio University, School of Medicine1,000
Terminated
Phase 3
Efficacy of Retreatments With Intravitreal BevacizumabAge Related Macular DegenerationChoroidal Neovascularization
NCT00406744Asociación para Evitar la Ceguera en México20